| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.54B | +5.7% |
| Cost of Revenue | $2.56B | +4.4% |
| R&D Expense | $614.0M | +13.9% |
| SG&A Expense | $2.15B | +7.1% |
| Interest Expense | $239.0M | +8.1% |
| Pre-tax Income | $2.94B | +10.5% |
| Income Tax | $596.0M | +9.4% |
| Net Income | $2.34B | +10.9% |
| EPS (Basic) | $5.08 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.30B | +7.3% |
| Inventory | $2.56B | +9.3% |
| Current Assets | $6.34B | -15.5% |
| Total Assets | $14.29B | -4.3% |
| Current Liabilities | $1.89B | -40.4% |
| Long-term Debt | $6.56B | +0.2% |
| Total Liabilities | $9.29B | -11.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.35B | +23.1% |
| Capital Expenditures | $732.0M | +24.9% |
| Investing Cash Flow | -$777.0M | +12.0% |
| Financing Cash Flow | -$3.11B | -243.9% |
| Free Cash Flow | $1.62B | +22.2% |
| +12.6% |
| EPS (Diluted) | $5.07 | +12.9% |
| Stockholders' Equity |
| $5.00B |
| +13.4% |